Image
Figure Caption

Figure 3—figure supplement 1. Crispr/Cas9 targeting of zebrafish <italic>adrb2a</italic> and <italic>pgrmc1.</italic>

(A) Human PGRMC1and zebrafish Pgrmc1 contain a conserved Transmembrane (TM) domain (yellow) and a Cytochrome b5-like Heme/Steroid binding domain (blue). (B) Protein alignment of zebrafish Pgrmc1 to human PGRMC1. Identical residues are marked in black, similar residues in grey. (C) Crispr-Cas9 targeting of pgrmc1 generated an allele with a 16 bp deletion. The PAM sequence is indicated in red. (D) The predicted translation of pgrmc1 Δ16 leads to a premature stop codon. (E) Protein alignment of zebrafish Adrb2a and Adrb2b to human ADRB2. Identical residues are marked in black, similar residues in grey. The N-terminal region (pink) is the putative Aβ binding region. The C-terminal region is in green. (F) Crispr-Cas9 targeting of adrb2a generated an allele with an 8 bp deletion. The PAM sequence is indicated in red. (G) The predicted translation of adrb2aΔ8 leads to a premature stop codon lacking all functional domains.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Elife